GR3025376T3 - Salts of nefazodone having improved dissolution rates - Google Patents

Salts of nefazodone having improved dissolution rates

Info

Publication number
GR3025376T3
GR3025376T3 GR970403019T GR970403019T GR3025376T3 GR 3025376 T3 GR3025376 T3 GR 3025376T3 GR 970403019 T GR970403019 T GR 970403019T GR 970403019 T GR970403019 T GR 970403019T GR 3025376 T3 GR3025376 T3 GR 3025376T3
Authority
GR
Greece
Prior art keywords
salts
nefazodone
dissolution rates
improved dissolution
dissolution
Prior art date
Application number
GR970403019T
Other languages
English (en)
Inventor
Hemant N Joshi
Terry D Wilson
Jatin M Patel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of GR3025376T3 publication Critical patent/GR3025376T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR970403019T 1994-11-02 1997-11-13 Salts of nefazodone having improved dissolution rates GR3025376T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33339094A 1994-11-02 1994-11-02

Publications (1)

Publication Number Publication Date
GR3025376T3 true GR3025376T3 (en) 1998-02-27

Family

ID=23302579

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403019T GR3025376T3 (en) 1994-11-02 1997-11-13 Salts of nefazodone having improved dissolution rates

Country Status (10)

Country Link
US (1) US6034085A (el)
EP (1) EP0710653B1 (el)
JP (1) JPH08208480A (el)
AT (1) ATE157659T1 (el)
AU (1) AU689645B2 (el)
CA (1) CA2160423A1 (el)
DE (1) DE69500652T2 (el)
DK (1) DK0710653T3 (el)
ES (1) ES2107280T3 (el)
GR (1) GR3025376T3 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
PT1071425E (pt) * 1998-04-24 2007-11-16 Scarista Ltd ''tratamento da depressão e composições farmacêuticas para o efeito''
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2000025790A1 (en) * 1998-11-02 2000-05-11 Alza Corporation Controlled delivery of antidepressants
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
BRPI0418228B8 (pt) * 2003-12-31 2021-05-25 Cima Labs Inc forma de dosagem, e, método de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
US20060069060A1 (en) * 2004-09-27 2006-03-30 Sanjeev Redkar Salts of decitabine
US20060063735A1 (en) * 2004-09-17 2006-03-23 Supergen, Inc. Salts of 5-azacytidine
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
WO2009039414A2 (en) 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (vlpt)
CA2700474C (en) * 2007-09-21 2016-10-04 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (p120)
WO2009070507A2 (en) * 2007-11-27 2009-06-04 Idexx Laboratories, Inc. Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
MX2011003634A (es) * 2008-10-08 2011-05-02 Idexx Lab Inc Composiciones y metodos para la deteccion de anticuerpos especificos de anaplasma phagocytophilum (aph) y anaplasma platys (apl).
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
TW279864B (el) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv

Also Published As

Publication number Publication date
DE69500652T2 (de) 1998-02-19
EP0710653B1 (en) 1997-09-03
DE69500652D1 (de) 1997-10-09
EP0710653A1 (en) 1996-05-08
US6034085A (en) 2000-03-07
JPH08208480A (ja) 1996-08-13
CA2160423A1 (en) 1996-05-03
AU3458395A (en) 1996-05-09
AU689645B2 (en) 1998-04-02
DK0710653T3 (da) 1997-12-08
ES2107280T3 (es) 1997-11-16
ATE157659T1 (de) 1997-09-15

Similar Documents

Publication Publication Date Title
GR3025376T3 (en) Salts of nefazodone having improved dissolution rates
AR064896A2 (es) Composicion farmaceutica no higroscopica
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
LU91452I2 (fr) "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
LU91290I2 (fr) Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
HU0200688D0 (en) Pharmaceutical formulations with improved release containing solid salts of racemic thioctic acid
LU91306I2 (fr) Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
AU6945491A (en) Pimobendan compositions
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
ITRM950480A0 (it) Metodo per aumentare la rapidita' di allevamento di neonati mediante impiego di mangime per scrofe da riproduzione.
ZA914747B (en) Piperidyl-substituted indoles
ZA973495B (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route.
EP1069107A4 (en) FULLERENE DERIVATIVES
PH30969A (en) New N,N,N',N' tetrasubstituted-1,2-ethanediamine compounds.
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
AU6849594A (en) Orientation aid for use when swimming on the back
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
IL104049A0 (en) 7'-amino-naphthazarin antibiotic derivatives
FR2798279B1 (fr) Dispositif d'insemination artificielle, notamment pour la reproduction des porcs
FR2794328B1 (fr) Decodeur de sequence d'image pour avance rapide
ZA902167B (en) Thienylpiperazines,process for the preparation thereof,the use thereof,and pharmaceuticals containing these and the preparation thereof
ITPD950047A0 (it) Telecamera endoscopica, in particolare per la ripresa di immagini della cavita' orale
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin
FR2782444B1 (fr) Dispositif d'amelioration de la tetee des porcelets nouveaux-nes
PT82535A (en) Pharmacologically active propionylanilides